OrthoPediatrics Corp.
DE ˙ DB ˙ US68752L1008
15,50 € ↑1,50 (10,71%)
2026-06-05
DEL PRIS
SecurityDE:2X7 / OrthoPediatrics Corp.
InstitutionNorthern Trust Corp
Latest Disclosed Ownership150,431 shares
Latest Disclosed Value $ 2,387,339
Northern Trust Corp reports 3.11% decrease in ownership of 2X7 / OrthoPediatrics Corp.

On May 14, 2026 - Northern Trust Corp filed a 13F-HR form disclosing ownership of 150,431 shares of OrthoPediatrics Corp. (DE:2X7) valued at $1,955,603 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 155,252 shares of OrthoPediatrics Corp.. This represents a change in shares of -3.11% during the quarter. The current value of the position is $2,331,680 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F ORTHOPEDIATRICS COM 68752L100 150,431 -4,821 -3.11 2,387 -13.42 0.0001
2026-02-17 2025-12-31 13F ORTHOPEDIATRICS COM 68752L100 155,252 -19,771 -11.30 2,757 -14.99 0.0004
2025-11-14 2025-09-30 13F ORTHOPEDIATRICS COM 68752L100 175,023 -4,701 -2.62 3,243 -15.98 0.0004
2025-08-13 2025-06-30 13F ORTHOPEDIATRICS COM 68752L100 179,724 -12,438 -6.47 3,860 -18.43 0.0005
2025-05-13 2025-03-31 13F ORTHOPEDIATRICS COM 68752L100 192,162 -1,636 -0.84 4,733 5.34 0.0007
2025-02-14 2024-12-31 13F ORTHOPEDIATRICS COM 68752L100 193,798 644 0.33 4,492 -14.21 0.0006
2024-11-13 2024-09-30 13F ORTHOPEDIATRICS COM 68752L100 193,154 9,574 5.22 5,236 -0.81 0.0009
2024-08-14 2024-06-30 13F ORTHOPEDIATRICS COM 68752L100 183,580 4,506 2.52 5,280 1.11 0.0009
2024-05-14 2024-03-31 13F ORTHOPEDIATRICS COM 68752L100 179,074 -5,977 -3.23 5,222 -13.21 0.0009
2024-02-13 2023-12-31 13F ORTHOPEDIATRICS COM 68752L100 185,051 -36,983 -16.66 6,016 -15.33 0.0011
2023-11-13 2023-09-30 13F ORTHOPEDIATRICS COM 68752L100 222,034 -1,486 -0.66 7,105 -27.51 0.0014
2023-08-11 2023-06-30 13F ORTHOPEDIATRICS COM 68752L100 223,520 17,546 8.52 9,801 7.44 0.0019
2023-05-15 2023-03-31 13F ORTHOPEDIATRICS COM 68752L100 205,974 -232 -0.11 9,123 11.35 0.0018
2023-02-13 2022-12-31 13F ORTHOPEDIATRICS COM 68752L100 206,206 1,218 0.59 8,193 -13.39 0.0017
2022-11-14 2022-09-30 13F ORTHOPEDIATRICS COM 68752L100 204,988 -2,876 -1.38 9,458 5.45 0.0022
2022-08-12 2022-06-30 13F ORTHOPEDIATRICS COM 68752L100 207,864 -10,494 -4.81 8,969 -23.92 0.0019
2022-05-13 2022-03-31 13F ORTHOPEDIATRICS COM 68752L100 218,358 -12,687 -5.49 11,789 -14.76 0.0021
2022-02-08 2021-12-31 13F ORTHOPEDIATRICS COM 68752L100 231,045 -4,635 -1.97 13,830 -10.42 0.0023
2021-11-15 2021-09-30 13F ORTHOPEDIATRICS COM 68752L100 235,680 -2,714 -1.14 15,439 2.51 0.0027
2021-08-13 2021-06-30 13F ORTHOPEDIATRICS COM 68752L100 238,394 -1,734 -0.72 15,061 28.66 0.0027
2021-05-12 2021-03-31 13F ORTHOPEDIATRICS COM 68752L100 240,128 -3,868 -1.59 11,706 16.30 0.0022
2021-02-11 2020-12-31 13F ORTHOPEDIATRICS COM 68752L100 243,996 7,555 3.20 10,065 -7.29 0.0020
2020-11-16 2020-09-30 13F ORTHOPEDIATRICS COM 68752L100 236,441 7,010 3.06 10,857 8.13 0.0024
2020-08-14 2020-06-30 13F ORTHOPEDIATRICS COM 68752L100 229,431 30,212 15.17 10,041 27.13 0.0024
2020-05-14 2020-03-31 13F ORTHOPEDIATRICS COM 68752L100 199,219 14,915 8.09 7,898 -8.80 0.0023
2020-02-14 2019-12-31 13F ORTHOPEDIATRICS COM 68752L100 184,304 6,758 3.81 8,660 38.34 0.0019
2019-11-13 2019-09-30 13F ORTHOPEDIATRICS COM 68752L100 177,546 27,607 18.41 6,260 7.05 0.0015
2019-08-13 2019-06-30 13F ORTHOPEDIATRICS COM 68752L100 149,939 2,225 1.51 5,848 -10.50 0.0014
2019-05-13 2019-03-31 13F ORTHOPEDIATRICS COM 68752L100 147,714 12,571 9.30 6,534 38.64 0.0016
2019-02-12 2018-12-31 13F ORTHOPEDIATRICS COM 68752L100 135,143 31,787 30.75 4,713 24.45 0.0013
2018-11-14 2018-09-30 13F ORTHOPEDIATRICS COM 68752L100 103,356 14,493 16.31 3,787 59.99 0.0009
2018-09-18 2018-06-30 13F/A-1 ORTHOPEDIATRICS COM 68752L100 88,863 34,687 64.03 2,367 190.07 0.0006
2018-08-14 2018-06-30 13F ORTHOPEDIATRICS COM 68752L100 89,665 35,489 2,389
2018-05-09 2018-03-31 13F ORTHOPEDIATRICS COM 68752L100 54,176 14,344 36.01 816 6.81 0.0002
2018-02-14 2017-12-31 13F ORTHOPEDIATRICS COM 68752L100 39,832 39,832 764 0.0002
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.